Irlend et al. observed that MYC activates NOTCH signaling to dedifferentiate tumor cells from ASCL1+ to NEUROD1+ to the YAP1+ state, and they proposed that SCLC molecular subtypes are not distinct but instead show a dynamic stage of tumor evolution [42]. The gene discussed is MYC; the disease is small cell lung carcinoma.